Sign up for weekly webinars: https://imahealth.org/weekly-webinars/ign up for weekly webinars: Weekly Webinars - Independent Medical Alliance


What does the data show when Moderna’s mRNA flu vaccine is evaluated using absolute measures of benefit and risk?


IMA President and Chief Medical Officer Dr. Joseph Varon was joined by Dr. Peter McCullough, Nicolas Hulscher, and Dr. John Catanzaro to examine their new reanalysis of FDA clinical trial data for Moderna’s mFLUSIVA (mRNA-1010).


They discussed:

• The vaccine’s reported efficacy and absolute clinical benefit

• Adverse reactions and reactogenicity seen in the clinical trials

• Mortality findings highlighted in the authors’ reanalysis

• Why the authors believe the data raise unanswered questions about the vaccine’s benefit-risk profile and continued licensure


The Independent Medical Alliance (formerly FLCCC) is a healthcare nonprofit on a mission to restore trust, integrity, and the doctor-patient relationship. Get involved by clicking below:


• Donate: Support IMA: Donate for Advancements in Patient Care https://imahealth.org/donate/

• Follow: Connect with Us - https://imahealth.org/contact/

• Weekly Webinars: - https://imahealth.org/category/weekly-webinars/

• Treatment Protocols: - https://imahealth.org/treatment-protocols/

• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör by the IMA (Formerly FLCCC Alliance). Innehållet i podden är skapat av by the IMA (Formerly FLCCC Alliance) och inte av, eller tillsammans med, Poddtoppen.